Beijing Bio-targeting Therapeutics Technology Co., Ltd

This early-stage study is testing a new two-part treatment for aggressive brain cancer that has come back after standard therapy. It combines a specially engineered virus designed to infect and kill cancer cells with a drug that helps the immune system attack the tumor. The main …